TY  - JOUR 
AU  - Rico‐Sánchez, Laura
AU  - Garzón Bello, Ingrid Johanna
AU  - González Andrades, Miguel
AU  - Ruíz‐García, Antonio
AU  - Punzano, Miriam
AU  - Lizana Moreno, Antonio Manuel
AU  - Muñoz Ávila, José Ignacio
AU  - Sánchez Quevedo, María Del Carmen
AU  - Martínez‐Atienza, Juliana
AU  - López‐Navas, Luis
AU  - Sánchez‐Pernaute, Rosario
AU  - Oruezabal, Roke Iñaki
AU  - Medialdea Marcos, Santiago
AU  - González-Gallardo, María del Carmen
AU  - Carmona, Gloria
AU  - Sanbonmatsu-Gámez, Sara
AU  - Pérez, Matías
AU  - Jiménez, Pilar
AU  - Cuende Melero, Natividad
AU  - Campos Muñoz, Antonio Jesús
AU  - Alaminos Mingorance, Miguel
PY  - 2019
UR  - http://hdl.handle.net/10481/60848
AB  - Blindness due to corneal diseases is a common pathology affecting up to 23 million individuals worldwide. The tissue‐engineered anterior human cornea, which is currently being tested in a Phase I/II clinical trial to treat severe corneal trophic...
LA  - eng
PB  - Wiley
KW  - Advanced therapy medicinal products (ATMPs)
KW  - Clinical translation
KW  - Cornea
KW  - Preclinical research
KW  - Regulatory issues
KW  - Tissue‐engineered anterior human cornea (TEAHC)
KW  - Tissue engineering
TI  - Successful development and clinical translation of a novel anterior lamellar artificial cornea
DO  - 10.1002/term.2951
ER  -